Nomura Holdings
EVFM

Nomura Holdings’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Nomura Holdings’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-152
Closed -$8K – 1728
2016
Q1 		$8K Buy
+152
New +$11.8K ﹤0.01% 1512

Other funds holding EVFM

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's EVFM Position: Q2 2016 in Review

Nomura Holdings sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2016, closing a stake of 152 shares — an estimated $8K sold.

Nomura Holdings first reported a position in EVFM in Q1 2016 and held it in 1 quarter. The position peaked at $8K in Q1 2016. 17 funds tracked by Wall St. Rank hold EVFM as of Q2 2016.

  • Nomura Holdings reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Nomura Holdings sold 152 Evofem Biosciences, Inc. Common Stock shares in Q2 2016, an estimated $8K.
  • Nomura Holdings first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Nomura Holdings's Evofem Biosciences, Inc. Common Stock position peaked at $8K in Q1 2016.
  • 17 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.